EU Approves Roche's Polivy Combination For Previously Untrea

SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) said that the European Commission has granted approval of Polivy or polatuzumab vedotin in combination with MabThera or rituximab plus cyclophosphamide

Related Keywords

, European Union , European Commission , Approves , Oche , Polivy , Combination , Reviously , Untreated , Diffuse , Barge , Fell , Lymphoma ,